Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Clinical Roundup

Inavolisib combination reduces PFS advanced HR+, HER2- breast cancer with PIK3CA mutation

December 15, 2023
Vol.49 No.46
Clinical Roundup

Trial shows atezolizumab combined with carboplatin has efficacy in TNBC

December 15, 2023
Vol.49 No.46
Clinical Roundup

Women at high risk of breast cancer find novel decision-aid tool helpful, pilot study shows

December 15, 2023
Vol.49 No.46
In Brief

UF Health Cancer Center to launch mobile mammography unit and expand access to care

December 08, 2023
Vol.49 No.45
Funding Opportunities

Breast Cancer Research Program anticipated funding opportunity for FY24

December 08, 2023
Vol.49 No.45
Drugs & Targets

FDA approves Truqap + fulvestrant for breast cancer

November 17, 2023
Vol.49 No.43
In Brief

The Max Foundation provides targeted treatment for advanced breast cancer patients in Mozambique at no cost

November 10, 2023
Vol.49 No.42
Clinical Roundup

“GPS” seed devices found effective in locating breast tumors in retrospective UC study

November 03, 2023
Vol.49 No.41
Clinical Roundup

Phase III NATALEE trial: Kisqali demonstrates risk of recurrence in early breast cancer

October 27, 2023
Vol.49 No.40
Clinical Roundup

Five-year monarchE outcome data demonstrate Verzenio’s long-term impact on cancer recurrence in high-risk early breast cancer

October 27, 2023
Vol.49 No.40

Posts navigation

Previous1…171819…32Next

Trending Stories

  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
  • NCI slated to get a $9 million raise as Trump’s budget proposes about 10% cut for NIH
  • FDA’s guidance on MRD in MM goes beyond the ODAC vote—and that’s where it matters most
    Draft guidance consolidates trial design updates for developers
  • Trump imposes up to 100% tariff on some brand name pharmaceutical companies
  • Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account